Stay updated with breaking news from Jonathan Birt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mestag Therapeutics ('Mestag'), an immunotherapy company focusing on fibroblast-immune interactions, and VIB, the leading life science research...
/PRNewswire/ -- Mestag Therapeutics ("Mestag"), an immunotherapy company harnessing new insights into fibroblast-immune interactions in cancer and inflammatory...
Gynov SAS announces investment from eureKARE SA eureKARE SA will bring long-term expertise, financial and operational support to GynovFinancing will boost the development of the product pipeline
- Simon Sturge a un parcours riche et accompli de 40 ans dans le secteur de la biotechnologie et de l'industrie pharmaceutique, le plus récemment en tant que...
eureKARE launches with $60 million to build and finance next generation biotech companies in Europe B innovation eureKARE accompanied by a hig May 2021: eureKARE ("the Company"), a pioneering new company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, today announces its launch with a $60 million Series A financing. The financing was supported by high-net worth investors and family offices. eureKARE is focused on two emerging and cutting-edge fields of research that have the potential to disrupt an...